Roche’s Actemra Helps Critically Ill Covid Patients in Test

(Bloomberg) -- Roche Holding AG’s rheumatoid arthritis medicine Actemra helps severely ill patients survive Covid-19, according to the early results of an international clinical trial.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.